Mechanism of erosion of nanostructured porous silicon drug carriers in neoplastic tissues

Nature Communications

Volumn 6, Issue , 2015, Pages

  Tzur Balter, Adi ^a   Shatsberg, Zohar ^b   Beckerman, Margarita ^b   Segal, Ester ^a   Artzi, Natalie ^b,c  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Massachusetts Institute of Technology Cambridge   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CARRIER; NANOMATERIAL; REACTIVE OXYGEN METABOLITE; SILICON;

CATALYSIS; NANOTECHNOLOGY; OXYGEN; POROUS MEDIUM; SILICON; SURFACE AREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCOMPATIBILITY; BREAST CANCER; CANCER TISSUE; CATALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG RETENTION; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; POROSITY; TUMOR MICROENVIRONMENT; ANIMAL; CHEMISTRY; FLUORESCENCE; METABOLISM; NEOPLASM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DRUG CARRIERS; FLUORESCENCE; HUMANS; MICE; NANOSTRUCTURES; NEOPLASMS; POROSITY; REACTIVE OXYGEN SPECIES; SILICON; TUMOR MICROENVIRONMENT;

EID: 84923108418     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7208     Document Type: Article

References (58)

1. Brigger, I., Dubernet, C. & Couvreur, P. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 64, 24-36 (2002).
2. Stastny, M. et al. HPMA-hydrogels containing cytostatic drugs-kinetics of the drug release and in vivo efficacy. J. Control. Release 81, 101-111 (2002).
3. Wise, D. L. Handbook of Pharmaceutical Controlled Release Technology 1st edn (Marcel Dekker Inc., 2000).
4. Liu, Q. Y., Jiang, L., Shi, R. & Zhang, L. Q. Synthesis, preparation, in vitro degradation, and application of novel degradable bioelastomers-A review. Prog. Polym. Sci. 37, 715-765 (2012).
5. Nair, L. S. & Laurencin, C. T. Biodegradable polymers as biomaterials. Prog. Polym. Sci. 32, 762-798 (2007).
6. Rodriguez-Galan, A., Franco, L. & Puiggali, J. Degradable poly(ester amide)s for biomedical applications. Polymers 3, 65-99 (2011).
7. Ulery, B. D., Nair, L. S. & Laurencin, C. T. Biomedical applications of biodegradable polymers. J. Polym. Sci. Pt. B Polym. Phys. 49, 832-864 (2011).
8. Anderson, J. M. Biological responses to materials. Ann. Rev. Mater. Res. 31, 81-110 (2001).
9. Artzi, N. et al. In vivo and in vitro tracking of erosion in biodegradable materials using non-invasive fluorescence imaging. Nat. Mater. 10, 704-709 (2011).
10. Bonanno, L. M. & Segal, E. Nanostructured porous silicon-polymer-based hybrids: from biosensing to drug delivery. Nanomedicine 6, 1755-1770 (2011).
11. Anglin, E. J., Cheng, L. Y., Freeman, W. R. & Sailor, M. J. Porous silicon in drug delivery devices and materials. Adv. Drug Deliv. Rev. 60, 1266-1277 (2008).
12. Park, J. H. et al. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat. Mater. 8, 331-336 (2009).
13. Salonen, J. et al. Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs. J. Control. Release 108, 362-374 (2005).
14. Canham, L. T. Bioactive silicon structure fabrication through nanoetching techniques. Adv. Mater. 7, 1033-1037 (1995).
15. Canham, L. T. Nanoscale semiconducting silicon as a nutritional food additive. Nanotechnology 18, 6 (2007).
16. Jane, A., Dronov, R., Hodges, A. & Voelcker, N. H. Porous silicon biosensors on the advance. Trends Biotechnol. 27, 230-239 (2009).
17. Kilian, K. A., Boecking, T. & Gooding, J. J. The importance of surface chemistry in mesoporous materials: lessons from porous silicon biosensors. Chem. Commun. 6, 630-640 (2009).
18. Massad-Ivanir, N., Shtenberg, G. & Segal, E. Advancing nanostructured porous si-based optical transducers for label free bacteria detection. Adv. Exp. Med. Biol. 733, 37-45 (2012).
19. Cunin, F. et al. Biomolecular screening with encoded porous-silicon photonic crystals. Nat. Mater. 1, 39-41 (2002).
20. Coffer, J. L. et al. Porous silicon-based scaffolds for tissue engineering and other biomedical applications. Phys. Status Solidi A 202, 1451-1455 (2005).
21. Sun, W., Puzas, J. E., Sheu, T. J. & Fauchet, P. M. Porous silicon as a cell interface for bone tissue engineering. Phys. Status Solidi A 204, 1429-1433 (2007).
22. Sun, W., Puzas, J. E., Sheu, T. J., Liu, X. & Fauchet, P. M. Nano-to microscale porous silicon as a cell interface for bone-tissue engineering. Adv. Mater. 19, 921-924 (2007).
23. Bimbo, L. M. et al. Drug permeation across intestinal epithelial cells using porous silicon nanoparticles. Biomaterials 32, 2625-2633 (2011).
24. Chiappini, C. et al. Tailored porous silicon microparticles: fabrication and properties. Chemphyschem. 11, 1029-1035 (2010).
25. Li, X. et al. Porosified silicon wafer structures impregnated with platinum anti-tumor compounds: fabrication, characterization, and diffusion studies. Biomed. Microdevices 2, 265-272 (2000).
26. Park, J. S., Kinsella, J. M., Jandial, D. D., Howell, S. B. & Sailor, M. J. Cisplatin-loaded porous Si microparticles capped by electroless deposition of platinum. Small 7, 2061-2069 (2011).
27. Perelman, L. A., Pacholski, C., Li, Y. Y., VanNieuwenhze, M. S. & Sailor, M. J. pH-triggered release of vancomycin from protein-capped porous silicon films. Nanomedicine 3, 31-43 (2008).
28. Salonen, J., Kaukonen, A. M., Hirvonen, J. & Lehto, V. P. Mesoporous silicon in drug delivery applications. J. Pharm. Sci. 97, 632-653 (2008).
29. Tasciotti, E. et al. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat. Nanotechnol. 3, 151-157 (2008).
30. Anglin, E. J., Schwartz, M. P., Ng, V. P., Perelman, L. A. & Sailor, M. J. Engineering the chemistry and nanostructure of porous Silicon Fabry-Perot films for loading and release of a steroid. Langmuir 20, 11264-11269 (2004).
31. Gu, L. et al. In vivo time-gated fluorescence imaging with biodegradable luminescent porous silicon nanoparticles. Nat. Commun. 4, 7 (2013).
32. Martinez, J. O. et al. Short and long term, in vitro and in vivo correlations of cellular and tissue responses to mesoporous silicon nanovectors. Small 9, 1722-1733 (2013).
33. Tzur-Balter, A., Gilert, A., Massad-Ivanir, N. & Segal, E. Engineering porous silicon nanostructures as tunable carriers for mitoxantrone dihydrochloride. Acta Biomater. 9, 6208-6217 (2013).
34. Xiao, L., Gu, L., Howell, S. B. & Sailor, M. J. Porous silicon nanoparticle photosensitizers for singlet oxygen and their phototoxicity against cancer cells. ACS Nano 5, 3651-3659 (2011).
35. Yokoi, K. et al. Porous silicon nanocarriers for dual targeting tumor associated endothelial cells and macrophages in stroma of orthotopic human pancreatic cancers. Cancer Lett. 334, 319-327 (2013).
36. Tzur-Balter, A., Young, J. M., Bonanno-Young, L. M. & Segal, E. Mathematical modeling of drug release from nanostructured porous Si: combining carrier erosion and hindered drug diffusion for predicting release kinetics. Acta Biomater. 9, 8346-8353 (2013).
37. Wu, E. C. et al. Real-time monitoring of sustained drug release using the optical properties of porous silicon photonic crystal particles. Biomaterials 32, 1957-1966 (2011).
38. Wu, E. C. et al. Oxidation-triggered release of fluorescent molecules or drugs from mesoporous si microparticles. ACS Nano 2, 2401-2409 (2008).
39. Gu, L., Park, J. H., Duong, K. H., Ruoslahti, E. & Sailor, M. J. Magnetic luminescent porous silicon microparticles for localized delivery of molecular drug payloads. Small 6, 2546-2552 (2010).
40. Alvarez, S. D., Derfus, A. M., Schwartz, M. P., Bhatia, S. N. & Sailor, M. J. The compatibility of hepatocytes with chemically modified porous silicon with reference to in vitro biosensors. Biomaterials 30, 26-34 (2009).
41. Kovalainen, M. et al. Mesoporous silicon (PSi) for sustained peptide delivery: effect of PSi microparticle surface chemistry on peptide YY3-36 release. Pharm. Res. 29, 837-846 (2012).
42. Anderson, S. H. C., Elliott, H., Wallis, D. J., Canham, L. T. & Powell, J. J. Dissolution of different forms of partially porous silicon wafers under simulated physiological conditions. Physica Status Solidi A 197, 331-335 (2003).
43. Godin, B. et al. Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation. J. Biomed. Mater. Res. A 94A, 1236-1243 (2010).
44. Tasciotti, E. et al. Near-infrared imaging method for the in vivo assessment of the biodistribution of nanoporous silicon particles. Mol. Imag. 10, 56-68 (2011).
45. Bruska, A., Chernook, A., Hietschold, M. & von Borczyskowski, C. Spectroscopic and SEM investigations of porous silicon doped with dyes. Appl. Surf. Sci. 102, 427-430 (1996).
46. Canham, L. T. Laser dye impregnation of oxidized porous silicon on silicon wafers. Appl. Phys. Lett. 63, 337-339 (1993).
47. Letant, S. & Vial, J. C. Energy transfer in dye impregnated porous silicon. J. Appl. Phys. 82, 397-401 (1997).
48. Setzu, S., Letant, S., Solsona, P., Romestain, R. & Vial, J. C. Improvement of the luminescence in p-type as-prepared or dye impregnated porous silicon microcavities. J. Lumin. 80, 129-132 (1998).
49. Setzu, S., Solsona, P., Letant, S., Romestain, R. & Vial, J. C. Microcavity effect on dye impregnated porous silicon samples. Eur. Phys. J. Appl. Phys. 7, 59-63 (1999).
50. Acikgoz, S. et al. Investigation of fluorescence dynamics of BODIPY embedded in porous silicon and monitoring formation of a SiO2 layer via a confocal FLIM-based NSET method. J. Phys. Chem. C 115, 22186-22190 (2011).
51. Sciacca, B., Pace, S., Rivolo, P. & Geobaldo, F. Switching of fluorescence mediated by a peroxynitrite-glutathione redox reaction in a porous silicon nanoreactor. Phys. Chem. Chem. Phys. 14, 5251-5254 (2012).
52. Toyokuni, S., Okamoto, K., Yodoi, J. & Hiai, H. Persistent oxidative stress in cancer. FEBS Lett. 358, 1-3 (1995).
53. Lee, S. H., Gupta, M. K., Bang, J. B., Bae, H. & Sung, H. J. Current progress in reactive oxygen species (ROS)-responsive materials for biomedical applications. Adv. Healthc. Mater. 2, 908-915 (2013).
54. Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P. & Lipton, S. A. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-Aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl Acad. Sci. USA 92, 7162-7166 (1995).
55. Hogg, N., Darleyusmar, V. M., Wilson, M. T. & Moncada, S. Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem. J. 281, 419-424 (1992).
56. Dairou, J., Atmane, N., Rodrigues-Lima, F. & Dupret, J. M. Peroxynitrite irreversibly inactivates the human xenobiotic-metabolizing enzyme arylamine N-Acetyltransferase 1 (NAT1) in human breast cancer cells-A cellular and mechanistic study. J. Biol. Chem. 279, 7708-7714 (2004).
57. Decuzzi, P. et al. Size and shape effects in the biodistribution of intravascularly injected particles. J. Control. Release 141, 320-327 (2010).
58. Hartmann, K. I. et al. Hydrosilylated porous silicon particles function as an intravitreal drug delivery system for daunorubicin. J. Ocul. Pharmacol. Ther. 29, 493-500 (2013).